PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
150.82%
Some net income increase while CRON.TO is negative at -40.32%. John Neff would see a short-term edge over the struggling competitor.
-15.84%
Negative yoy D&A while CRON.TO is 49.75%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
-49.99%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
-61.06%
Both cut yoy SBC, with CRON.TO at -13.89%. Martin Whitman would view it as an industry shift to reduce stock-based pay or a sign of reduced expansions.
222.65%
Slight usage while CRON.TO is negative at -381.04%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
-6666.34%
Both yoy AR lines negative, with CRON.TO at -366.35%. Martin Whitman would suspect an overall sector lean approach or softer demand.
-33.64%
Both reduce yoy inventory, with CRON.TO at -140.78%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
6284.67%
A yoy AP increase while CRON.TO is negative at -148.96%. John Neff would see competitor possibly improving relationships or liquidity more rapidly.
726.12%
Some yoy usage while CRON.TO is negative at -165.52%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
-81.72%
Negative yoy while CRON.TO is 42.72%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
89.50%
Some CFO growth while CRON.TO is negative at -217.42%. John Neff would note a short-term liquidity lead over the competitor.
7.97%
Some CapEx rise while CRON.TO is negative at -13.13%. John Neff would see competitor possibly building capacity while we hold back expansions.
167.48%
Acquisition spending well above CRON.TO's 100.00%. Michael Burry would suspect heavier integration risk or short-term free cash flow drain vs. competitor.
-189.72%
Both yoy lines negative, with CRON.TO at -1485481.70%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
-157.46%
Both yoy lines are negative, with CRON.TO at -100.00%. Martin Whitman suspects an environment prompting fewer sales or fewer maturities within the niche.
102.18%
We have some outflow growth while CRON.TO is negative at -40.88%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
-157.66%
Both yoy lines negative, with CRON.TO at -14519.02%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
-1718.51%
We cut debt repayment yoy while CRON.TO is 99.78%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
-102.18%
Negative yoy issuance while CRON.TO is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
No Data
No Data available this quarter, please select a different quarter.